{
    "organizations": [],
    "uuid": "79fc1d556057e635ca8a5b77983b574cca041151",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-glycomimetics-enters-agreement-wit/brief-glycomimetics-enters-agreement-with-hovon-to-initiate-study-startup-activities-for-planned-clinical-trial-of-gmi-1271-and-decitabine-idUSASB0C4TA",
    "ord_in_thread": 0,
    "title": "BRIEF-Glycomimetics Enters Agreement With Hovon To Initiate Study Startup Activities For Planned Clinical Trial Of GMI-1271 And Decitabine",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - Glycomimetics Inc:\n* GLYCOMIMETICS ENTERS INTO AGREEMENT WITH HOVON TO INITIATE STUDY STARTUP ACTIVITIES FOR PLANNED CLINICAL TRIAL OF GMI-1271 AND DECITABINE IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) WHO ARE UNFIT FOR CHEMOTHERAPY\n* GLYCOMIMETICS INC - ‍ON TRACK TO DISCLOSE DETAILS FOR DESIGN OF PHASE 3 TRIAL IN RELAPSED/REFRACTORY AML PATIENTS DURING 2017 YEAR-END EARNINGS CALL\n* GLYCOMIMETICS INC - ‍ HOVON INTENDS TO ENROLL APPROXIMATELY 140 PATIENTS IN CLINICAL TRIAL OF GMI-1271 AND DECITABINE​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-08T22:26:00.000+02:00",
    "crawled": "2018-02-09T16:38:15.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "glycomimetics",
        "inc",
        "glycomimetics",
        "enters",
        "agreement",
        "hovon",
        "initiate",
        "study",
        "startup",
        "activity",
        "planned",
        "clinical",
        "trial",
        "decitabine",
        "patient",
        "newly",
        "diagnosed",
        "acute",
        "myeloid",
        "leukemia",
        "aml",
        "unfit",
        "chemotherapy",
        "glycomimetics",
        "inc",
        "track",
        "disclose",
        "detail",
        "design",
        "phase",
        "trial",
        "aml",
        "patient",
        "earnings",
        "call",
        "glycomimetics",
        "inc",
        "hovon",
        "intends",
        "enroll",
        "approximately",
        "patient",
        "clinical",
        "trial",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}